| 前收市價 | 2.8300 |
| 開市 | 2.7700 |
| 買盤 | 0.0000 x 0 |
| 賣出價 | 0.0000 x 0 |
| 今日波幅 | 2.7700 - 3.0400 |
| 52 週波幅 | 1.7500 - 6.7500 |
| 成交量 | |
| 平均成交量 | 2,840 |
| 市值 | 8.239M |
| Beta 值 (5 年，每月) | 1.83 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -5.3900 |
| 業績公佈日 | 2024年5月09日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
Insider Monkey12 Best Biotech Penny Stocks to Invest In
In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Biotech Penny Stocks to Invest In. The past few years have been a topsy-turvy ride for the biotech sector. There was a massive increase in […]
BenzingaCyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New Investors
Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (formerly CY6463) and CY3018, to a new private company ("NewCo") formed by certain current Cyclerion shareholders and new investors who have agreed to invest $81 million. Cyclerion will receive $8 million as reimbursement for all expenses related to zagociguat and CY3018 between the signing and closing of the transaction and 10% equity ownership in NewCo. Cyclerion will also have additional future equity
